Hikma Pharmaceuticals Plc Director/PDMR Shareholding (9221Q)
03 March 2021 - 3:44AM
UK Regulatory
TIDMHIK
RNS Number : 9221Q
Hikma Pharmaceuticals Plc
02 March 2021
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Douglas Hurt
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Market purchase of 1,500 Ordinary Shares by
transaction Gillian Hurt, spouse of Douglas Hurt
c) Price(s) and Price(s): GBP22.65
volume(s) Volume(s): 1,500
d) Aggregated information
* Volume 1,500
GBP22.65
GBP33,975
* Price
* Total
e) Date of the transaction 2 March 2021
f) Place of the London Stock Exchange (XLON)
transaction
Peter Speirs
Company Secretary, responsible for releasing this
announcement
+44 (0) 20 7399 2760
2 March 2021
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBLGDXXSGDGBD
(END) Dow Jones Newswires
March 02, 2021 11:44 ET (16:44 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Apr 2024 to May 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From May 2023 to May 2024